000			02170 a2200601 4500
005			20250512132657.0
264		0	_c19690919
008			196909s 0 0 eng d
022			_a0365-5547
040			_aNLM _beng _cNLM
100	1		_aHolmes, E L
245	0	0	_aExperimental observations on flufenamic, mefenamic, and meclofenamic acids. IV. Toleration by normal human subjects. _h[electronic resource]
260			_bAnnals of physical medicine _c1966
300			_a36-49 p. _bdigital
500			_aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article
650	0	4	_aAdult
650	0	4	_aAnti-Inflammatory Agents _xadverse effects
650	0	4	_aAspirin _xpharmacology
650	0	4	_aBiphenyl Compounds _xanalysis
650	0	4	_aBlood Coagulation _xdrug effects
650	0	4	_aBlood Urea Nitrogen
650	0	4	_aChlorides _xurine
650	0	4	_aClinical Trials as Topic
650	0	4	_aConstipation _xchemically induced
650	0	4	_aDiarrhea _xchemically induced
650	0	4	_aDigestive System _xdrug effects
650	0	4	_aDrug Tolerance
650	0	4	_aExanthema _xchemically induced
650	0	4	_aFlatulence _xchemically induced
650	0	4	_aFlufenamic Acid _xadministration & dosage
650	0	4	_aFluorine _xadverse effects
650	0	4	_aHeadache _xchemically induced
650	0	4	_aHeartburn _xchemically induced
650	0	4	_aHumans
650	0	4	_aKidney Function Tests
650	0	4	_aMale
650	0	4	_aMefenamic Acid _xadministration & dosage
650	0	4	_aMethods
650	0	4	_aMuscle Cramp _xchemically induced
650	0	4	_aOccult Blood
650	0	4	_aPlacebos
650	0	4	_aPotassium _xurine
650	0	4	_aProthrombin _xanalysis
650	0	4	_aSleep Initiation and Maintenance Disorders _xchemically induced
650	0	4	_aSodium _xtherapeutic use
650	0	4	_aUric Acid _xurine
650	0	4	_aVertigo _xchemically induced
650	0	4	_aVision Disorders _xchemically induced
650	0	4	_aVomiting _xchemically induced
650	0	4	_aWarfarin _xtherapeutic use
650	0	4	_aortho-Aminobenzoates _xadverse effects
773	0		_tAnnals of physical medicine _gvol. Suppl _gp. 36-49
999			_c4897941 _d4897941